Tarsus Pharmaceuticals, Inc.
TARS· Nasdaq
Released Mar 13, 2023, after the close
10-K filed Mar 17, 2023, 76 days after period end · 0001819790-23-000007
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $10.00M | $338.00K | $0.00 | — |
| Net Income | -$13.60M |
Tarsus Pharmaceuticals, Inc. · CIK 1819790 · Engraved from SEC EDGAR
| -$14.85M |
| -$11.47M |
| -$1.41M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.